COLL vs KO
Collegium Pharmaceutical Inc (COLL) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the COLL and KO stock pages for the full models.
Not investment advice.